SCHEMBL12766534

SCHEMBL12766534

C=C(CC)C(=O)c1ccc(OCC(=O)CCCCCO[Si](C)(C)C(C)(C)C)c(Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 15/20 0.56
▸ GSTA1 P08263 9/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ ABCC3 O15438 1/20 0.56
▸ PLIN1 O60240 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ LMNA P02545 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ HSPD1 P10809 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ MAP2K6 P52564 1/20 0.56
▸ HSPE1 P61604 1/20 0.56
▸ GSTO1 P78417 1/20 0.56
▸ PLIN5 Q00G26 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ ATM Q13315 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1524705 0.85 GSTP1 (0.54) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL12766535 0.83 GSTP1 (0.67) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL12766538 0.82 GSTP1 (0.65) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL1524310 0.81 GSTP1 (0.49) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL10031684 0.78 GSTP1 (0.80) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL9717593 0.77 GSTP1 (0.71) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL12766539 0.77 GSTP1 (0.53) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL9717476 0.76 GSTP1 (0.73) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL22260541 0.75 GSTP1 (0.71) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL10001222 0.75 GSTP1 (0.74) GSTP1GSTA1MEN1ABCC3PLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130156701-A1 METHOD OF PREPARING ETHACRYNIC AMIDE DERIVATIVES AND APPLICATION THEREOF NATIONAL TSING HUA UNIVERSITY (TW) 2013-06-20 — — US disclosed
US-20110077430-A1 Method and precursor for production of no-carrier-added N-(4-[18F] fluorobutyl)-Ethacrynic amide INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) 2011-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130156701-A1 METHOD OF PREPARING ETHACRYNIC AMIDE DERIVATIVES AND APPLICATION THEREOF FAP, ALK, PIGO GSTP1 66/4885GSTA1 130/4885MEN1 155/4885
US-20110077430-A1 Method and precursor for production of no-carrier-added N-(4-[18F] fluorobutyl)-Ethacrynic amide PFAS, NAPA, NAA15 GSTP1 233/4885GSTA1 66/4885MEN1 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback